Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
Working Capital/Sales

    Back to All Ratios
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

VENUS REMEDIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 2.052.152.313.244.01

What is the latest Working Capital/Sales ratio of VENUS REMEDIES ?

The latest Working Capital/Sales ratio of VENUS REMEDIES is 2.05 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20252.05
Mar20242.15
Mar20232.31
Mar20223.24
Mar20214.01

How is Working Capital/Sales of VENUS REMEDIES Trending?

Years Working Capital/Sales % Change
Mar2025 2.05
-4.65
Mar2024 2.15
-6.93
Mar2023 2.31
-28.70
Mar2022 3.24
-19.20
Mar2021 4.01 -

Other Financial Ratios of VENUS REMEDIES


Compare Working Capital/Sales ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹1,299.1 Cr 12.1% 38.3% 194.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,150.0 Cr -0.9% -3.9% 1.3% Stock Analytics
DIVIS LABORATORIES ₹156,129.0 Cr -0.4% -7.6% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,312.0 Cr -2% -7.5% 27.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,445.2 Cr -1.5% -9.3% 3.8% Stock Analytics
CIPLA ₹98,210.2 Cr 1.7% -8.3% -16.8% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

12.1%

38.3%

194.7%

SENSEX

7.8%

-2%

0.2%


You may also like the below Video Courses